Amoxicillin — Drug Intelligence | 28 EU Trials

Filter these 28 trials by condition, phase, country and more.

Open in Search →

28 Registered trials

20 Recruiting

3 Completed trials

20 Sponsors

15 Countries

Phase III

Phase II

Phase IV

Phase III: 9 Phase II/III: 1 Phase II: 4 Phase III/IV: 2 Phase IV: 12

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Medical device site joint infection 1 Abdominal infection 1 Endocarditis bacterial 1 Infection 1 Urinary tract infection 1 Brain abscess 1 Spinal cord injury 1 Bacterial infection 1 Erythema migrans 1 Sepsis 1 Antibiotic therapy 1 Endocarditis enterococcal 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 4 Centre Hospitalier Universitaire De Nantes 3 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 2 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 2 Rigshospitalet 2 Aalborg University Hospital 1 Biocodex 1 Centre Hospitalier Universitaire Amiens Picardie 1 CHU Gabriel-Montpied 1 Complutense University Of Madrid 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Karolinska Institutet 1

All trials

28 total

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
Comparison of two prophylactic antibiotic regimens in case of preterm prelabor rupture of membranes before 34 weeks of gestation: a randomiz… Pending

2025-520842-31-00 Phase III 1 country Assistance Publique Hopitaux De Paris
AMOXICILLIN VERSUS AMOXICILLIN-CLAVULANATE VERSUS PLACEBO IN ACUTE OTITIS MEDIA IN CHILDREN Pending

2025-524259-30-00 Phase III/IV 1 country Pohjois-Savon hyvinvointialue
LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending

2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
A Study to Evaluate a New Treatment Option for Helicobacter pylori Infection Compared to First Line Treatment. Pending

2026-525291-26-00 Phase III 1 country Verisfield Single Member S.A.
Effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans… Recruiting

2023-508694-80-01 Phase IV 4 countries Biocodex
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-labe… Recruiting

2023-506843-40-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
The effect of systemic antibiotics on post-surgical complications and patient-centered outomes in patients undergoing implant surgery with t… Recruiting

2025-521185-10-00 Phase IV 1 country Complutense University Of Madrid
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Phase IV 1 country Rigshospitalet
BuLLSEYE Recruiting

2024-512950-13-00 Phase III/IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis Recruiting

2024-519969-21-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Efficacy of antibiotic treatment for patients with chronic low back pain Recruiting

2024-515824-35-01 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Acute non-severe osteomyelitis in children Recruiting

2024-516744-26-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting

2023-506224-87-00 Phase II 1 country Mikrobiomik Healthcare Company S.L.
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Amoxicillin alone versus amoxicillin/clavulanate for community-acquired pneumonia in patients aged 65 years or older, and hospitalized in a … Recruiting

2023-503645-63-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting

2023-507617-96-01 Phase IV 1 country Rigshospitalet
CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP] Recruiting

2023-504208-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting

2022-502974-18-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20) Recruiting

2024-517402-28-00 Phase II 1 country Karolinska Institutet
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.

Showing 1–24 of 28 trials

← All drugs A–Z